Serum sortilin-derived propeptide concentrations as markers of depression in chronic stroke
These findings suggest serum sortilin-derived propeptide could be a useful biomarker for post-stroke depression. This opens up potential new treatment approaches, including the consideration of the drug spadin, which targets this peptide, for managing post-stroke depression in humans.
Authors
- Catherine Heurteaux (ORCID: https://orcid.org/0000-0002-9741-9777)
- Marc Borsotto (ORCID: https://orcid.org/0000-0002-1302-7419)
- Anne-Marie Mendyk
- Jean Mazella (ORCID: https://orcid.org/0000-0002-5627-0742)
- Thibaut Dondaine (ORCID: https://orcid.org/0000-0002-8778-5079)
- Régis Bordet (ORCID: https://orcid.org/0000-0003-3916-6422)
- Bertrand Accart
- Estelle Mazella
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Université Côte d'Azur (FR)
- Université de Lille (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- Institut de Pharmacologie Moléculaire et Cellulaire (FR)
- Lille Neurosciences & Cognition (FR)
Publication Details
- Journal
- Journal of the Neurological Sciences
- Published
- 2025-03-08
- DOI
- https://doi.org/10.1016/j.jns.2025.123459
- Citations
- 2
- Primary Topic
- Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.68